HCG: Device, Neurovascular Embolization
What it covers
A neurovascular embolization device is an intravascular implant intended to permanently occlude blood flow to cerebral aneurysms and cerebral ateriovenous malformations. This does not include cyanoacrylates and other embolic agents, which act by polymerization or precipitation. Embolization devices used in other vascular applications are also not included in this classification, see § 870.3300.
The identification in 21 CFR 882.5950, neurovascular embolization device. FDA gives HCG no definition of its own, so the regulation’s describes it.
FDA flags HCG devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262419 | MICRUSFRAME (MFR100202); MICRUSFRAME (MFR100253); MICRUSFRAME (MFR100305); MICRUSFRAME (MFR100356); MICRUSFRAME (MFR100407); MICRUSFRAME (MFR100412); MICRUSFRAME (MFR100509); MICRUSFRAME (MFR100517); MICRUSFRAME (MFR100611); MICRUSFRAME (MFR100626); MICRUSFRAME (MFR100713); MICRUSFRAME (MFR100730); MICRUSFRAME (MFR100816); MICRUSFRAME (MFR100829); MICRUSFRAME (MFR140225); MICRUSFRAME (MFR140303); MICRUSFRAME (MFR140304); MICRUSFRAME (MFR140306); MICRUSFRAME (MFR140406); MICRUSFRAME (MF | Cerenovus, Inc. | Aug 14, 2026 | Special |
| K261772 | Target Xtra Detachable Coil | Stryker Neurovscular | Jun 24, 2026 | Special |
| K260351 | Numen Helia Coil Embolization System; NumenFR Detachment System | MicroPort NeuroTech (Shanghai) Co., Ltd. | May 20, 2026 | Special |
| K254221 | Optima Coil System (OptiOne Coil System) | Balt USA, LLC | Jan 27, 2026 | Special |
| K252694 | Target Detachable Coil | Stryker Neurovascular | Dec 11, 2025 | Traditional |
| K251832 | InZone IST Detachment System; IZDS Connecting Cable | Stryker Neurovascular | Oct 17, 2025 | Special |
| K252700 | Optima Coil System (Optima Packing Coil System) | Balt USA, LLC | Sep 26, 2025 | Special |
| K242154 | Numen Coil Embolization System; NumenFR Detachment System | MicroPort NeuroTech (Shanghai) Co., Ltd. | Sep 30, 2024 | Special |
| K242582 | Optima Coil System (OptiBlock Line Extension) | Balt USA, LLC | Sep 27, 2024 | Special |
| K242243 | Target Detachable Coils | Stryker Neurovscular | Aug 29, 2024 | Special |
Clearances by year
73 HCG 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 4 | 30 |
| 2025 | 3 | 107 |
| 2024 | 4 | 49 |
| 2023 | 2 | 147 |
| 2022 | 3 | 114 |
| 2021 | 5 | 103 |
| 2020 | 2 | 147 |
| 2019 | 1 | 30 |
| 2018 | 4 | 173 |
| 2017 | 5 | 97 |
| 2016 | 7 | 37 |
| 2015 | 5 | 60 |
| 2014 | 5 | 66 |
| 2013 | 7 | 67 |
| 2012 | 7 | 30 |
| 2011 | 9 | 78 |
Who submits
20 applicants cleared a HCG device since 2011. 92% of the clearances went to applicants in United States, then China (5%) and Switzerland (3%). By type: Special 67% and Traditional 33%.
| Applicant | Clearances since 2011 |
|---|---|
| MicroVention, Inc. | 13 |
| Stryker Neurovascular | 11 |
| Penumbra, Inc. | 10 |
| Blockade Medical | 6 |
| Codman & Shurtleff, Inc. | 6 |
| Balt USA, LLC | 5 |
| Micro Therapeutics, Inc. d/b/a ev3 Neurovascular | 4 |
| MicroPort NeuroTech (Shanghai) Co., Ltd. | 4 |
How FDA classifies it
Class II (special controls.) The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.” For availability of this guidance document, see § 882.1(e).
From 21 CFR 882.5950. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 882.5950 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent HCG clearances declared.
Ask about HCG
Questions about HCG
What is FDA product code HCG?
Product code HCG, “Device, Neurovascular Embolization” in FDA's classification database, is a Class II device type under 21 CFR 882.5950 (neurovascular embolization device), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 187 clearances under HCG, 73 of them since 2011.
How many 510(k) clearances are there under HCG?
FDA’s 510(k) database listed 187 clearances under HCG as of Oct 29, 2026, 73 of them decided since 2011; the most recent decision was Aug 14, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a HCG 510(k)?
For the 7 HCG clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 30 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most HCG clearances?
Since 2011: MicroVention, Inc. (13), Stryker Neurovascular (11), Penumbra, Inc. (10), Blockade Medical (6) and Codman & Shurtleff, Inc. (6). 20 applicants have cleared a HCG device in that time.